Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 282 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1492. Clear
Clear
2A
MERCK & CO, INC. for MERCK & CO INC
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Animals
View →
Q3
LUNDBECK LLC for LUNDBECK LLC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q3
THE MCMANUS GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
2A
AMGEN, INC. for AMGEN INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View →
Q3
AMGEN, INC. for AMGEN INC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View →
Q3
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security
View →
Q3
BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Agriculture, Tariff (miscellaneous tariff bills), Budget/Appropriations, Copyright/Patent/Trademark
View →
Q3
MARSHALL & POPP, LLC for SANOFI U.S. SERVICES, INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Taxation/Internal Revenue Code
View →
Q3
NOVARTIS for NOVARTIS
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q3
MARSHALL & POPP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $40,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q3
MARSHALL & POPP, LLC for PFIZER, INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Taxation/Internal Revenue Code
View →
Q3
WILLIAMS AND JENSEN, PLLC for PHRMA
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Trade (domestic/foreign), Medicare/Medicaid, Health Issues, Budget/Appropriations
View →
Q3
MARSHALL & POPP, LLC for GENENTECH, INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q3
BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View →
Q3
JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate
Taxation/Internal Revenue Code, Veterans, Trade (domestic/foreign), Health Issues
View →
Q3
THE MCMANUS GROUP for GILEAD SCIENCES, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q3
THE MCMANUS GROUP for GENENTECH
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code
View →
Q3
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Pharmacy
View →
Q3
THE MCMANUS GROUP for AMGEN
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q3
MARSHALL & POPP, LLC for AMGEN USA INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q3
THE MCMANUS GROUP for EMD SERONO, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View →
Q3
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations
View →
Q3
NEUROCRINE BIOSCIENCES, INC for NEUROCRINE BIOSCIENCES, INC
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Medicare/Medicaid, Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code
View →
Q3
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues
View →
Q3
W STRATEGIES, LLC for MERCK & CO., INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · $50,000.00 income
Medicare/Medicaid
View →
Previous Page 6 of 12 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem